Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

BACKGROUND: Glioblastoma (GBM) is the most common and lethal primary malignant glioma in adults. Dendritic cell (DC) vaccines have demonstrated promising results in GBM clinical trials. However, some patients do not respond well to DC therapy, with survival rates similar to those of conventional the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jan, Chia-Ing, Tsai, Wan-Chen, Harn, Horng-Jyh, Shyu, Woei-Cherng, Liu, Ming-Chao, Lu, Hsin-Man, Chiu, Shao-Chih, Cho, Der-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992384/
https://www.ncbi.nlm.nih.gov/pubmed/29910795
http://dx.doi.org/10.3389/fimmu.2018.00727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992384/
https://www.ncbi.nlm.nih.gov/pubmed/29910795
http://dx.doi.org/10.3389/fimmu.2018.00727

Ejemplares similares